Ke gula koloidal
-
Pahu ʻike antibody IgM/IgG o ka maʻi Chikungunya (Colloidal gold)
[Inoa Huahana]Pahu ʻike antibody IgM/IgG o ka maʻi Chikungunya (Colloidal gold)
[HuahanaKōkuhi]HWTS-FE062
[Manaʻo Hoʻohana]
Ua manaʻo ʻia kēia pahu no ka ʻike ʻana i nā antibodies ma ke ʻano in vitro
e kūʻē i ka maʻi Chikungunya (me IgM a me IgG), a hoʻohana ʻia ma ke ʻano he lāʻau lapaʻau
ka hōʻailona kōkua no ka maʻi Chikungunya.
-
Lāʻau Palekana ʻAspirin
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o nā polymorphisms ma ʻekolu mau loci genetic o PEAR1, PTGS1 a me GPIIIa i nā hāpana koko holoʻokoʻa kanaka.
-
Koko Pohihihi Fecal
Hoʻohana ʻia ka pahu hana no ka ʻike ʻana i ka hemoglobin kanaka i loko o nā hāpana ʻōpala kanaka a no ka ʻike mua ʻana i ke kahe koko ʻana o ka ʻōpū.
He kūpono kēia pahu hana no ka hoʻāʻo ponoʻī ʻana e ka poʻe ʻoihana ʻole, a hiki ke hoʻohana ʻia e nā limahana lapaʻau ʻoihana e ʻike i ke koko i loko o nā ʻōpala i nā keʻena lapaʻau.
-
ʻO ka Antigen Metapneumovirus Kanaka
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o nā antigens metapneumovirus kanaka i loko o ka swab oropharyngeal, nā swab nasal, a me nā laʻana swab nasopharyngeal.
-
ʻO ka maʻi Monkeypox IgM/IgG Antibody
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o nā antibodies virus monkeypox, me IgM a me IgG, i loko o ke serum kanaka, plasma a me nā hāpana koko holoʻokoʻa.
-
Hemoglobin a me Transferrin
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka nui o ka hemoglobin kanaka a me ka transferrin i loko o nā hāpana ʻōpala kanaka.
-
Ua hui pū ʻia ʻo HBsAg a me HCV Ab
Hoʻohana ʻia ka pahu hana no ka ʻike ʻana i ka qualitative o ka hepatitis B surface antigen (HBsAg) a i ʻole ka antibody hepatitis C virus i loko o ke serum kanaka, plasma a me ke koko holoʻokoʻa, a kūpono ia no ke kōkua ʻana i ka ʻike ʻana i nā maʻi i manaʻo ʻia he maʻi HBV a i ʻole HCV a i ʻole ka nānā ʻana i nā hihia ma nā wahi me nā helu maʻi kiʻekiʻe.
-
Ua hui pū ʻia ʻo SARS-CoV-2, ka Influenza A&B Antigen, ka Respiratory Syncytium, Adenovirus a me Mycoplasma Pneumoniae
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka SARS-CoV-2, ka antigen influenza A&B, ka Respiratory Syncytium, adenovirus a me ka mycoplasma pneumoniae i loko o ka swab nasopharyngeal, ka swab oropharyngeal a me nā laʻana swab nasal in vitro, a hiki ke hoʻohana ʻia no ka ʻike ʻokoʻa o ka maʻi coronavirus hou, ka maʻi respiratory syncytial virus, adenovirus, mycoplasma pneumoniae a me ka maʻi influenza A a i ʻole B. No ka ʻike lapaʻau wale nō nā hopena hoʻāʻo, ʻaʻole hiki ke hoʻohana ʻia ma ke ʻano he kumu wale nō no ka ʻike a me ka mālama ʻana.
-
Ua hui pū ʻia ʻo SARS-CoV-2, Respiratory Syncytium, a me ka Influenza A&B Antigen
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi respiratory syncytial a me nā antigens influenza A&B in vitro, a hiki ke hoʻohana ʻia no ka ʻike ʻokoʻa o ka maʻi SARS-CoV-2, ka maʻi respiratory syncytial, a me ka maʻi influenza A a i ʻole B [1]. No ka ʻike lapaʻau wale nō nā hopena hoʻāʻo a ʻaʻole hiki ke hoʻohana ʻia ma ke ʻano he kumu hoʻokahi no ka ʻike a me ka mālama ʻana.
-
ʻOXA-23 Carbapenemase
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o nā OXA-23 carbapenemases i hana ʻia i loko o nā hāpana bacteria i loaʻa ma hope o ka moʻomeheu in vitro.
-
ʻO Clostridium Difficile Glutamate Dehydrogenase (GDH) a me ka Toxin A/B
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka Glutamate Dehydrogenase (GDH) a me Toxin A/B in vitro i loko o nā hāpana ʻōpala o nā hihia clostridium difficile i manaʻo ʻia.
-
ʻO ke kāpapenemase
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o NDM, KPC, OXA-48, IMP a me VIM carbapenemases i hana ʻia i loko o nā hāpana bacteria i loaʻa ma hope o ka moʻomeheu in vitro.
